Home
Resources
Diseases
Compendium
Training
Evaluation
The Tool
The Tutorial
The Dashboard
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Selected
COVID-19
Type of publications
Guidelines (1)
NITAG documentation (354)
SAGE documentation (33)
Scientific publications (4)
Systematic reviews (SYSVAC) (1121)
Regions
Africa (59)
Americas (187)
Eastern Mediterranean (10)
Europe (155)
South-East Asia (11)
Western Pacific (36)
Diseases
COVID-19 (1513)
Chikungunya (9)
Cholera (34)
Cytomegalovirus (1)
Dengue (40)
Diphtheria (80)
Ebola (16)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (68)
Hepatitis A (64)
Hepatitis B (157)
Hepatitis C (4)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (68)
HIV / AIDS (10)
Human papillomavirus (HPV) (493)
Influenza (581)
Japanese encephalitis (34)
Lyme disease, Borreliosis (1)
Malaria (28)
Measles (130)
Meningococcal disease (148)
Moraxella catarrhalis (1)
Mpox (55)
Mumps (46)
Pertussis (105)
Pneumococcal disease (277)
Poliomyelitis (86)
Q fever (1)
Rabies (29)
Rotavirus (117)
RSV (Respiratory syncytial virus) (48)
Rubella (64)
Salmonella (3)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (60)
Tick-borne encephalitis (12)
Tuberculosis (77)
Typhoid (24)
Varicella (71)
Yellow fever (42)
Zika (1)
Show more
Methodological quality (AMSTAR 2)
High (12)
Moderate (8)
Low (116)
Critically low (703)
Not applicable (282)
1513 results found
2020
∙
Beth Bell, ACIP
ACIP COVID-19 Vaccines Work Group - overview of American vaccines in development
2020
∙
JCVI
Advice on priority groups for COVID-19 vaccination
2020
∙
Thomas Clark, ACIP
Anaphylaxis Following m-RNA COVID-19 Vaccine Receipt
2020
∙
Ines Campos-Matos, Sema Mandal
Annex A: COVID-19 vaccine and health inequalities: considerations for prioritisation and implementation
2020
∙
ATAGI
ATAGI COVID-19 Working Group terms of reference and membership
2020
∙
William Gruber, ACIP
BNT162b2 Vaccine Candidate Against COVID-19
2020
∙
CAVEI
CAVEI interim recommendation for the initial prioritization of groups to be vaccinated against SARS-CoV-2 in the context of limited supply
2020
∙
CAVEI
CAVEI Interim statement on target groups for vaccination against SARS-COV-2
2020
∙
CAVEI
CAVEI ordinary meeting August 26th 2020
2020
∙
CAVEI
CAVEI ordinary meeting August 5th 2020
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register